Novel Biomarkers in Hemodialysis (HD) Patients and Their Clinical Outcomes
A special issue of Kidney and Dialysis (ISSN 2673-8236).
Deadline for manuscript submissions: closed (15 November 2023) | Viewed by 554
Special Issue Editors
2. Department of Biochemistry, CARIM, Maastricht University, Maastricht, The Netherlands
Interests: antibodies; hemodialysis; vaccines; CKD; CVD; biomarkers
2. Unit of Immunology and Chronic Disease, Institute of Environmental Medicine, Karolinska Institutet, 17177 Stockholm, Sweden
Interests: immunoinformatics; vaccines; biomarkers; bioinformatics; clinical informatics
Special Issue Information
Dear Colleagues,
In 2016, the incidence of end-stage renal disease (ESRD) reached 3.7 million and has been increasing by 5 to 6 percent annually. Along with the increase in elderly patients with end-stage renal disease (ESRD), several important pathophysiologies in hemodialysis (HD) patients, such as accelerating systemic atherosclerosis, vascular calcification, malnutrition, inflammation, frailty, and cognitive disturbance, have been recently uncovered. The negative events and prognosis of HD patients are intricately influenced by these diseases. Excessive elimination of important compounds in the body, or conversely, insufficient removal of toxic substances by HD treatment, may be inversely related to HD pathogenesis. In contrast, there have been considerable advancements in dialysis treatment. Depending on the patient's condition, various membranes and dialysis methods can be chosen. In this Special Issue, we invite writers to submit papers on the clinical use of hemodialysis (HD), the beneficial effects of various dialysis membranes and modalities, unfavorable adverse effects, and HD patient-specific pathophysiology, biomarkers, etc.
The topics covered in this Special Issue are as follows:
- Pathology and pathophysiology of acute renal failure
- Nephrotoxicity of drugs and other substances
- Prevention, treatment, and therapy of renal failure
- Transplantation, hypertension, and diabetes mellitus in association with renal failure
- Biomarkers
- Metabolic networks modeling
- Genetics of renal disease
- Critical care nephrology
- Bioinformatics for Renal and Urinary Proteomics
- Regulatory mechanisms of renal fibrosis
- Network-based transcriptomic analysis
Dr. Shailesh Kumar Samal
Pritam Kumar Panda
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Kidney and Dialysis is an international peer-reviewed open access quarterly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- antibody
- chronic kidney disease
- cardiovascular disease risk factors
- immune system
- molecular modeling
- meta-bolic networks
